Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Tae Hyun Kim is a pioneering translational researcher whose work bridges regenerative medicine, surgical oncology, and advanced cancer therapeutics. His most impactful contributions lie in bone tissue engineering, where he demonstrated that human induced pluripotent stem cells (hiPSCs) can be cultured directly on macrochanneled poly(caprolactone) scaffolds—bypassing the embryoid body step—to generate reliable osteogenic cells for bone repair (62 citations). This innovation offers a scalable, efficient pathway for skeletal regeneration. In surgical oncology, Dr. Kim has advanced minimally invasive techniques, notably through a comparative study of robotic versus laparoscopic radical hysterectomy for cervical cancer (39 citations), providing critical evidence for optimizing patient outcomes. He also led a phase II multi-institutional clinical trial (KROG 11-02) establishing the efficacy of a two-week preoperative chemoradiotherapy regimen followed by delayed surgery for rectal cancer (25 citations), a protocol that reduces treatment duration without compromising results. By integrating stem cell biology with clinical trial design, Dr. Kim’s work directly impacts both laboratory protocols and patient care, making him a key figure in translating stem cell science into practical surgical and oncological therapies.